16 members of Congress have disclosed 86 trades in Novo Nordisk A S (NVO) since 2014: 51 purchases worth about $1.19M and 35 sales worth about $1.23M. The most active was Kevin Hern, with 2 trades. The latest trade was made on Sep 10, 2026.
NVO’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought NVO, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kevin HernR-OK | 2 | 0 | 2 | $0.00 | $16.00K | -$16.00K | – | Aug 31, 2026 | Sep 10, 2026 |
| 2 | Scott FranklinR-FL | 7 | 7 | 0 | $105.00K | $0.00 | +$105.00K | -43.9% | Mar 27, 2025 | Aug 26, 2026 |
| 3 | Ro KhannaD-CA | 10 | 5 | 5 | $64.50K | $40.00K | +$24.50K | -75.9% | Mar 26, 2022 | Mar 13, 2026 |
| 4 | Lisa C. McClainR-MI | 7 | 3 | 4 | $24.00K | $32.00K | -$8.00K | -47.2% | Jun 9, 2025 | Oct 31, 2025 |
| 5 | Marjorie Taylor GreeneR-GA | 3 | 3 | 0 | $48.50K | $0.00 | +$48.50K | -43.1% | Aug 19, 2025 | Oct 15, 2025 |
| 6 | Val T. HoyleD-OR | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | -93.2% | Oct 29, 2024 | Oct 29, 2024 |
| 7 | Michael T. McCaulR-TX | 23 | 16 | 7 | $790.01K | $306.00K | +$484.00K | -107.4% | Apr 23, 2024 | Jul 30, 2025 |
| 8 | Laurel M. LeeR-FL | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | May 8, 2025 | May 8, 2025 |
| 9 | Byron DonaldsR-FL | 4 | 2 | 2 | $16.00K | $16.00K | $0.00 | -129.6% | Oct 7, 2022 | Mar 20, 2025 |
| 10 | John JamesR-MI | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -130.7% | Nov 10, 2023 | Sep 4, 2024 |
| 11 | Daniel S. GoldmanD-NY | 2 | 0 | 2 | $0.00 | $550.00K | -$550.00K | – | Jul 10, 2023 | Jul 12, 2023 |
| 12 | Katherine M. ClarkD-MA | 7 | 4 | 3 | $32.00K | $24.00K | +$8.00K | -125.3% | Oct 11, 2016 | Sep 16, 2021 |
| 13 | Mikie SherrillD-NJ | 2 | 0 | 2 | $0.00 | $16.00K | -$16.00K | – | May 28, 2019 | Feb 20, 2020 |
| 14 | Charles J. "Chuck" FleischmannR-TN | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | -104.4% | Dec 21, 2016 | Dec 21, 2016 |
| 15 | James B. RenacciR-OH | 13 | 7 | 6 | $80.50K | $213.00K | -$132.50K | -211.2% | Jul 17, 2014 | Sep 23, 2016 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kevin HernR-OK | NVONovo Nordisk A/S Common Stock | Self | Sell (Partial) | $1K–$15K | Aug 31, 2026 | Sep 25, 2026 | 25d | -10.7% | -8.8% | |
| Kevin HernR-OK | NVONovo Nordisk A/S Common Stock | Self | Sell | $1K–$15K | Sep 10, 2026 | Sep 25, 2026 | 15d | -8.1% | -7.3% | |
| Scott FranklinR-FL | NVONovo Nordisk A/S Common Stock | Self | Buy | $1K–$15K | Aug 26, 2026 | Sep 17, 2026 | 22d | -14.3% | -12.4% | |
| Ro KhannaD-CA | NVONOVO-NORDISK A/S ADR ADR CMN | Spouse | Buy | $1K–$15K | Mar 13, 2026 | Apr 7, 2026 | 25d | +6.6% | -7.0% | |
| Ro KhannaD-CA | NVONOVO-NORDISK A/S ADR ADR CMN | Spouse | Buy | $1K–$15K | Feb 13, 2026 | Mar 9, 2026 | 24d | -18.4% | -28.7% | |
| Lisa C. McClainR-MI | NVONovo Nordisk A/S Common Stock | Spouse | Sell | $1K–$15K | Oct 30, 2025 | Nov 21, 2025 | 22d | -19.1% | -29.8% | |
| Lisa C. McClainR-MI | NVONovo Nordisk A/S Common Stock | Spouse | Buy | $1K–$15K | Oct 30, 2025 | Nov 21, 2025 | 22d | -19.1% | -29.8% | |
| Lisa C. McClainR-MI | NVONovo Nordisk A/S Common Stock | Spouse | Sell | $1K–$15K | Oct 31, 2025 | Nov 21, 2025 | 21d | -18.2% | -28.5% | |
| Lisa C. McClainR-MI | NVONovo Nordisk A/S Common Stock | Spouse | Buy | $1K–$15K | Sep 11, 2025 | Oct 22, 2025 | 41d | -25.5% | -39.9% | |
| Marjorie Taylor GreeneR-GA | NVONovo Nordisk A/S Common Stock | Self | Buy | $1K–$15K | Oct 15, 2025 | Oct 20, 2025 | 5d | -28.7% | -41.7% | |
| Lisa C. McClainR-MI | NVONovo Nordisk A/S Common Stock | Spouse | Sell (Partial) | $1K–$15K | Aug 4, 2025 | Sep 12, 2025 | 39d | -17.1% | -36.3% | |
| Val T. HoyleD-OR | NVONovo Nordisk A/S Common Stock | Spouse | Buy | $1K–$15K | Oct 29, 2024 | Sep 12, 2025 | 318d late | -63.9% | -93.2% | |
| Marjorie Taylor GreeneR-GA | NVONovo Nordisk A/S Common Stock | Self | Buy | $1K–$15K | Aug 28, 2025 | Aug 29, 2025 | 1d | -27.9% | -43.8% | |
| Marjorie Taylor GreeneR-GA | NVONovo Nordisk A/S Common Stock | Self | Buy | $15K–$50K | Aug 19, 2025 | Aug 20, 2025 | 1d | -26.1% | -43.7% | |
| Scott FranklinR-FL | NVONovo Nordisk A/S Common Stock | Self | Buy | $15K–$50K | Aug 4, 2025 | Aug 14, 2025 | 10d | -17.1% | -36.3% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
16 members of Congress have disclosed 86 trades in Novo Nordisk A S (NVO) since 2014: 51 purchases worth about $1.19M and 35 sales worth about $1.23M. The most active was Kevin Hern, with 2 trades. The latest trade was made on Sep 10, 2026. Most active: Kevin Hern (2), Scott Franklin (7), Ro Khanna (10), Lisa C. McClain (7), Marjorie Taylor Greene (3).
Since 2014 they have disclosed 51 purchases and 35 sales; by the midpoints of the disclosed ranges, about $1.19M bought and $1.23M sold, a net sale of $36.49K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded NVO on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.